D.A. Davidson & Co
FTXH icon

D.A. Davidson & Co’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

D.A. Davidson & Co’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.7M Buy
+89,274
New +$3.59M 0.02% 517
2022
Q3 		– Sell
-239,586
Closed -$6.33M – 1313
2022
Q2 		$6.33M Buy
+239,586
New +$6.33M 0.08% 206

Other funds holding FTXH

Nilsine Partners
Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Daymark Wealth Partners
Daymark Wealth Partners Cincinnati, Ohio $4.41B AUM 22.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
TriaGen Wealth Management
TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return
Spire Wealth Management
Spire Wealth Management Mclean, Virginia $3.27B AUM 30.11% 1-Year Est. Return
Cyndeo Wealth Partners
Cyndeo Wealth Partners St. Petersburg, Florida $2.21B AUM 17.29% 1-Year Est. Return
Trust Company of Oklahoma
Trust Company of Oklahoma Tulsa, Oklahoma $377M AUM 28.32% 1-Year Est. Return
MinichMacGregor Wealth Management
MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

D.A. Davidson & Co's FTXH Position: Q3 2026 in Review

D.A. Davidson & Co opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2026: 89,274 shares worth $3.7M. The stake represents 0.02% of the portfolio and ranks #517 among its holdings. This is a return to the name: D.A. Davidson & Co previously reported a position in FTXH as recently as Q2 2022.

D.A. Davidson & Co first reported a position in FTXH in Q2 2022 and has held it in 2 quarters since. The position peaked at $6.33M in Q2 2022. 23 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.

  • D.A. Davidson & Co held 89,274 shares of First Trust Nasdaq Pharmaceuticals ETF worth $3.7M as of Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF was a new D.A. Davidson & Co position in Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up 0.02% of D.A. Davidson & Co's portfolio in Q3 2026, its #517 holding.
  • D.A. Davidson & Co first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2022 and has held it in 2 quarters since.
  • D.A. Davidson & Co's First Trust Nasdaq Pharmaceuticals ETF position peaked at $6.33M in Q2 2022.
  • 23 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.

Based on D.A. Davidson & Co's 13F filing for Q3 2026, filed 28 Oct 2026.